Skip to main content
OpenTrials
Completed

NCT Number: NCT00284492

Acupuncture for Hot Flushes in Menopause

In a pragmatic study investigate whether Traditional Chinese Medicine acupuncture-care decreases the frequency of hot flushes and increases health related quality of life among postmenopausal women. The intervention group will receive 10 sessions of acupuncture, the control group will engage in self care only. The study period lasts for 12 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Research Center, University Hospital of North Norway

Tromsø, No-9038, Norway

About this study

The study objective is to determine whether Traditional Chinese Medicine (TCM) acupuncture-care together with self-care is more effective than self-care alone, to relieve climacteric complaints among women who seek alternatives to hormonal replacement therapy (HRT). Study design is a pragmatic randomised controlled trial with two parallel arms. Study participants are postmenopausal women who document a mean value of 7 flushes/24 hours and who are not using HRT or other prescribed medication that may influence climacteric complaints. The treatment group will receive 10 sessions of TCM acupuncture-care and self-care; the control group will engage in self-care only.

The duration of intervention period is 12 weeks with evaluations at baseline, 4, 8, 12 weeks, and follow up at 6 and 12 months after baseline. Primary endpoint is change in daily hot flush frequency in the two groups from baseline to 12 weeks; secondary endpoint is health related quality of life. N in each treatment group: 143 (286 altogether).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postmenopausal women (at least one year past the last menstrual period) who are willing to receive acupuncture and who during two weeks of self-completed diaries10 document a mean value of 7 flushes/24 hours or more (or 50 flushes or more over a period of seven consecutive days), will be randomized after a baseline evaluation.
  • Current users prescribed medications that influence hot flush rate (e. g. HRT, SSRI's) can be included after a washout period. The washout-periods are eight weeks for SSRI's and systemic (including transdermal) HRT and four weeks for local estradiol preparations

Exclusion criteria

  • Surgical menopause
  • History of cancer within the past five years
  • Use of anticoagulant drugs
  • Heart valve disease
  • Poorly controlled hypertension
  • Hypothyroidism
  • Hyperthyroidism or diabetes mellitus
  • Organ transplant
  • Mental disease
  • Overt drug or alcohol dependency
  • Inability to complete study forms

Treatment and study plan

Traditional chinese medicine type acupuncture

Procedure

10 acupuncture sessions

Self Care

Behavioral

Lifestyle advice on diet, physical activity

Primary outcomes

  1. Frequency of hot flushes

    Time frame: 12 weeks

Secondary outcomes

  1. Health related quality of life (Women's Health Questionnaire)

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

University Hospital of North Norway

Other

Collaborators

  • The Research Council of Norway
  • University of Tromso

Registry information

Official study title

Effectiveness of Acupuncture-care for Treatment of Hot Flushes Among Postmenopausal Women

Acronym: ACUFLASH

Important dates

Study start
2006
Primary completion
2007
Study completion
2008
First posted
Jan 31, 2006
Registry last updated
May 14, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.